SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-233373
Filing Date
2021-08-02
Accepted
2021-08-02 16:46:16
Documents
12
Period of Report
2021-08-02
Items
Item 2.02: Results of Operations and Financial Condition

Document Format Files

Seq Description Document Type Size
1 8-K d186780d8k.htm   iXBRL 8-K 23767
  Complete submission text file 0001193125-21-233373.txt   150410

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA rna-20210802.xsd EX-101.SCH 2917
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE rna-20210802_lab.xml EX-101.LAB 18886
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rna-20210802_pre.xml EX-101.PRE 11877
5 EXTRACTED XBRL INSTANCE DOCUMENT d186780d8k_htm.xml XML 3483
Mailing Address 10975 N. TORREY PINES RD., #150 LA JOLLA CA 92037
Business Address 10975 N. TORREY PINES RD., #150 LA JOLLA CA 92037 858-401-7900
Avidity Biosciences, Inc. (Filer) CIK: 0001599901 (see all company filings)

IRS No.: 461336960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39321 | Film No.: 211136650
SIC: 2834 Pharmaceutical Preparations